Drug Enforcement Administration July 2011 – Federal Register Recent Federal Regulation Documents
Results 1 - 16 of 16
Denial of Petition To Initiate Proceedings To Reschedule Marijuana
By letter dated June 21, 2011, the Drug Enforcement Administration (DEA) denied a petition to initiate rulemaking proceedings to reschedule marijuana.\1\ Because DEA believes that this matter is of particular interest to members of the public, the agency is publishing below the letter sent to the petitioner (denying the petition), along with the supporting documentation that was attached to the letter.
Controlled Substances and List I Chemical Registration and Reregistration Fees
DEA proposes adjusting the fee schedule for DEA registration and reregistration fees necessary to recover the costs of its Diversion Control Program relating to the registration and control of the manufacture, distribution, dispensing, importation and exportation of controlled substances and List I chemicals as mandated by the Controlled Substances Act.
Establishment of a New Drug Code for Marihuana Extract
The Drug Enforcement Administration (DEA) is proposing to create a new Administration Controlled Substances Code Number (``Code Number'' or ``drug code'') under 21 CFR 1308.11 for ``Marihuana Extract.'' This Code Number will allow DEA and DEA-registered entities to track quantities of this material separately from quantities of marihuana. This in turn will aid in complying with relevant treaty provisions. Under international drug control treaties (administered by the United Nations), some differences exist between the regulatory controls pertaining to marihuana extract versus those for marihuana and tetrahydrocannabinols. DEA has established separate Code Numbers for marihuana and for tetrahydrocannabinols, but not for marihuana extract. To better track these materials and better comply with treaty provisions, DEA is proposing to create a separate Code Number for marihuana extract under 21 CFR 1308.11(d)(36): ``Marihuana Extract meaning extracts that have been derived from any plant of the genus cannabis and which contain cannabinols and cannabidiols.'' Such extracts of marihuana would continue to be treated as schedule I controlled substances.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.